Chinese Drug Developer Connect Biopharmaceuticals Completes $55 Million Series B Round

Login to View

Connect Biopharmaceuticals, a clinical-stage biotech medicine developer, has completed a US$55 million series B round of financing, led by private equity Advantech Capital, according to a company announcement released today.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Read 2 Articles for Free with a Basic Account

Gain limited and restricted access to China Money Network.

Register Basic Account

Subscribe for an annual subscription!

Enjoy comprehensive and exclusive data you can't find elsewhere!

More Info

Subscribe and Pay Easily Online!

Already have an account or paid subscription? Log in